New drug BT-114143 passes first safety check in healthy volunteers
Knowledge-focused
Completed
This early-stage trial tested a single injection of BT-114143 in 84 healthy adults to see if it is safe and how the body handles it. Participants received different doses or a placebo, and researchers monitored side effects and drug levels in the blood. Since this is a Phase 1 st…
Phase: PHASE1 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:57 UTC